Search details
1.
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Clin Infect Dis
; 76(3): e188-e199, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35796536
2.
Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.
Clin Infect Dis
; 76(3): e172-e178, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35869843
3.
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.
Am J Transplant
; 23(9): 1411-1424, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37270109
4.
Increasing Kidney-Exchange Options Within the Existing Living Donor Pool With CIAT: A Pilot Implementation Study.
Transpl Int
; 36: 11112, 2023.
Article
in English
| MEDLINE | ID: mdl-37342179
5.
Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function.
Kidney Int
; 101(6): 1251-1259, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35227691
6.
The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.
Nephrol Dial Transplant
; 36(9): 1761-1764, 2021 08 27.
Article
in English
| MEDLINE | ID: mdl-34450647
7.
Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
Ther Drug Monit
; 37(2): 262-9, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25265255
8.
The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
Nephrol Dial Transplant
; 29(8): 1587-97, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24771499
9.
Transplant Candidates of 70+ Years Have Superior Survival If Receiving Pre-Emptively a Living Donor Kidney.
J Clin Med
; 13(7)2024 Mar 23.
Article
in English
| MEDLINE | ID: mdl-38610618
10.
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients.
Viruses
; 15(7)2023 07 21.
Article
in English
| MEDLINE | ID: mdl-37515280
11.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Lancet Infect Dis
; 23(3): 307-319, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36354032
12.
Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.
NPJ Vaccines
; 8(1): 70, 2023 May 17.
Article
in English
| MEDLINE | ID: mdl-37198189
13.
Boosting the VZV-Specific Memory B and T Cell Response to Prevent Herpes Zoster After Kidney Transplantation.
Front Immunol
; 13: 927734, 2022.
Article
in English
| MEDLINE | ID: mdl-35935972
14.
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Transplantation
; 106(4): 821-834, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34753894
15.
Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of Transplanted Kidneys.
Transplant Proc
; 53(7): 2206-2211, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34376313
16.
Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors.
Front Immunol
; 12: 645718, 2021.
Article
in English
| MEDLINE | ID: mdl-33815403
17.
Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection.
Front Immunol
; 11: 1332, 2020.
Article
in English
| MEDLINE | ID: mdl-32719676
18.
The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Nephrol Dial Transplant
; 24(5): 1635-44, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19176684
19.
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment.
Clin Kidney J
; 17(5): sfae122, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38770045
20.
The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy.
Ann Transplant
; 23: 577-590, 2018 Aug 17.
Article
in English
| MEDLINE | ID: mdl-30115901